The nicotinic acetylcholine (ACh) receptor (nAChR) is the principal insecticide target. Nearly half of the insecticides by number and world market value are neonicotinoids acting as nAChR agonists or organophosphorus (OP) and methylcarbamate (MC) acetylcholinesterase (AChE) inhibitors. There was no previous evidence for in vivo interactions of the nAChR agonists and AChE inhibitors. The nitromethyleneimidazole (NMI) analog of imidacloprid, a highly potent neonicotinoid, was used here as a radioligand, uniquely allowing for direct measurements of house fly (Musca domestica) head nAChR in vivo interactions with various nicotinic agents. Nine neonicotinoids inhibited house fly brain nAChR [ 3 H]NMI binding in vivo, corresponding to their in vitro potency and the poisoning signs or toxicity they produced in intrathoracically treated house flies. Interestingly, nine topically applied OP or MC insecticides or analogs also gave similar results relative to in vivo nAChR binding inhibition and toxicity, but now also correlating with in vivo brain AChE inhibition, indicating that ACh is the ultimate OP-or MC-induced nAChR active agent. These findings on [ 3 H]NMI binding in house fly brain membranes validate the nAChR in vivo target for the neonicotinoids, OPs and MCs. As an exception, the remarkably potent OP neonicotinoid synergist, O-propyl O-(2-propynyl) phenylphosphonate, inhibited nAChR in vivo without the corresponding AChE inhibition, possibly via a reactive ketene metabolite reacting with a critical nucleophile in the cytochrome P450 active site and the nAChR NMI binding site.
The nicotinic acetylcholine (ACh) receptor (nAChR) is the principal insecticide target. Nearly half of the insecticides by number and world market value are neonicotinoids acting as nAChR agonists or organophosphorus (OP) and methylcarbamate (MC) acetylcholinesterase (AChE) inhibitors. There was no previous evidence for in vivo interactions of the nAChR agonists and AChE inhibitors. The nitromethyleneimidazole (NMI) analog of imidacloprid, a highly potent neonicotinoid, was used here as a radioligand, uniquely allowing for direct measurements of house fly (Musca domestica) head nAChR in vivo interactions with various nicotinic agents. Nine neonicotinoids inhibited house fly brain nAChR [ 3 H]NMI binding in vivo, corresponding to their in vitro potency and the poisoning signs or toxicity they produced in intrathoracically treated house flies. Interestingly, nine topically applied OP or MC insecticides or analogs also gave similar results relative to in vivo nAChR binding inhibition and toxicity, but now also correlating with in vivo brain AChE inhibition, indicating that ACh is the ultimate OP-or MC-induced nAChR active agent. These findings on [ T he nicotinic nervous system has two principal sites of insecticide action, the nicotinic receptor (nAChR) activated by acetylcholine (ACh) and neonicotinoid agonists (1) (2) (3) (4) (5) (6) , and acetylcholinesterase (AChE) inhibited by organophosphorus (OP) and methylcarbamate (MC) compounds to generate and maintain localized toxic ACh levels ( Fig. 1) (7) . The nAChR and AChE targets have been identified in insects by multiple techniques but not by direct assays of the ACh binding site in the brain of poisoned insects. Here we use the outstanding insecticidal potency of the nitromethyleneimidazole (NMI) analog of imidacloprid (IMI) (8) as a radioligand (9), designated [ 3 H]NMI, to directly measure the house fly (Musca domestica) nAChR not only in vitro but also in vivo, allowing us to validate by a previously undescribed method the neonicotinoid direct and OP/MC indirect nAChR targets (Fig. 2) . This approach also helped solve the intriguing mechanism by which an O-(2-propynyl) phosphorus compound strongly synergizes neonicotinoid insecticidal activity (10) by dual inhibition of cytochrome P450 (CYP) (11) (12) (13) and the nAChR agonist site (described herein). Insecticide disruption at the insect nAChR can now be readily studied in vitro and in vivo with a single radioligand allowing better understanding of the action of several principal insecticide chemotypes (Fig. 3) . (Fig. 4) .
Results
The toxicological relevance of the nAChR-neonicotinoid interactions was tested by determining dose-response and structureactivity relationships for nAChR binding inhibition versus poisoning signs. The results for dose-response ( Fig. 5A ) and structureactivity ( Fig. 5B ) both established nAChR binding inhibition closely related to poisoning signs (i.e., the [ 3 H]NMI assay is for a toxicologically relevant site in neonicotinoid poisoning). Thus, the findings with nine neonicotinoids confirmed a common target leading to the insecticidal activity.
nAChR-OP/MC Interactions. Paraoxon (PAR) and chlorpyrifos (CHL) were chosen to represent the direct-acting and bioactivated AChE inhibitors, respectively (7). As expected, neither one of these OPs inhibited nAChR binding of [ (Fig. 6A) . The studies, therefore, proceeded to test if there was a general relationship between nAChR binding inhibition and toxicity by examining varied doses of OP and MC compounds and assaying other insecticides.
Topically applied PAR and CHL established a clear doseresponse relationship for nAChR binding inhibition and poisoning signs with a similar correlation for the two compounds (Fig. 6B) . The nAChR binding inhibition-poisoning sign relationship was more firmly established with nine OPs and carbamates ( Fig. 7 A and B) . This process established that nAChR binding inhibition was associated with and possibly causal to the poisoning but the total lack of potency in vitro meant the OP
Significance
The insect nicotinic receptor is the direct or indirect target for neonicotinoids, organophosphorus compounds, and methylcarbamates, which make up about 45% of the insecticides by number and world market value. In this study, the house fly brain nicotinic receptor in vivo interactions with neurotoxicants are revealed by a unique radioligand reporter assay, providing direct in vivo proof of events at the receptor level leading to poisoning by these three major insecticide chemotypes.
was metabolically bioactivated (an unlikely event for PAR) or that another binding inhibitor was formed such as elevated ACh levels from AChE inhibition. (1) were found to be inactive in vitro (1,000 nM) and in vivo (100 μg/g intrathoracic injection, 1 h posttreatment) assayed for nAChR binding inhibition with [ 3 H]NMI as above: the nicotinic blocking agent cartap (14) ; the nicotinic activator spinosad (15) ; the GABA/glutamate receptor modulators fipronil, endosulfan, and avermectin; and the voltage-gated Na + channel modulators deltamethrin, allethrin, and DDT (1).
nAChR-PPP Synergist Interactions. PPP (prop-2-yn-1-yl propyl phenylphosphonate) (Fig. 8 ) is a remarkably effective CYP inhibitor and synergist for neonicotinoid insecticides, leading to the question of what is so unusual about this compound. PPP is not a direct inhibitor of Musca nAChR binding or AChE, with little or no inhibition of either target in vitro at 10,000 nM. PPP in vivo at 100 μg/g inhibits nAChR binding without inducing poisoning signs, in contrast to all of the other OPs and carbamates examined. PPP inhibits nAChR binding in vivo but not in vitro, and is a less-effective AChE inhibitor in vivo than the other OPs. This finding leads to the hypothesis that PPP, with its unusual O-propynyl substituent, undergoes bioactivation not only to a CYP inhibitor, but also to a nAChR binding inhibitor acting at a site that does not lead to nAChR activation or produce prominent poisoning signs. As a first step in understanding PPP metabolism, it was administrated to mice and the urine was examined for a propionic acid metabolite formed via a ketene intermediate (Fig. 8) . The propionic acid metabolite was identified by LC/MS comparison with a synthetic standard (m/z = 272.66) and cochromatography (R t = 23.92 min), as described in SI Text. The PPP ketene is therefore a candidate activated intermediate in the nAChR binding inhibition and synergist action (16). This high-affinity radioligand with a rapid association and slow dissociation rate (9) can be used to record the in vivo binding site of the Musca nAChR, either normal or altered, by toxic action (Fig. 2) . It is applicable to neonicotinoid agonists and OP and MC AChE inhibitors. No disruption was found for nicotinic agents cartap and spinosad acting at other sites and with a variety of insecticides toxic by other mechanisms.
Discussion
Nicotinic Agonist-nAChR Interactions. The Musca nAChR assay with [ 3 H]NMI is very sensitive to neonicotinoids in vitro and in vivo. The potencies of the neonicotinoids depend on the balance of their nAChR association and dissociation rates. The neonicotinoid potency in vitro is generally a good predictor of the in vivo effects.
Anticholinesterase-nAChR Interactions. A great variety of OP chemotypes and some MCs are potent nAChR binding inhibitors in vivo but not in vitro. Our earlier studies showed desnitro-IMI is Fig. 1 . The insect nicotinic receptor is the direct or indirect target for neonicotinoids, organophosphorus compounds and methylcarbamates, which make up about 45% of the insecticides by number and world market value (2, 7). a nAChR binding inhibitor in vivo in mouse brain (17) . As an exception, physostigmine is a direct nAChR binding inhibitor in Musca but at a different site in the receptor (18) . Poisoning by anticholinesterases, both OPs and MCs, is easily monitored by AChE inhibition in the head of poisoned Musca (19) . In the present study the MC carbofuran was highly effective in both AChE and nAChR binding inhibition. Freshly decapitated Musca are similar to normal Musca in OP sensitivity, indicating that action at a site other than the brain plays a role in poisoning (20) . PPP lacks the AChE-associated toxic effects of other OPs indicating that, in this case, the brain is more an indicator than a direct target of the insecticidal action. In any case, the in vivo nAChR binding inhibition by most OPs and MCs is undoubtedly a result of AChE inhibition (19) , and accumulation of the endogenous ACh agonist (21) that serves as a potent inhibitor in this type of binding assay (22) .
PPP Synergist-nAChR Interactions. PPP is far more effective than the most important commercial insecticide synergist piperonyl butoxide in enhancing neonicotinoid toxicity, and at the dose used here it increases the topical potency of several neonicotinoids by 50-to 100-fold (10) . PPP is an exception to the proposed OP phosphorylation of AChE, leading to ACh accumulation and nAChR binding inhibition. PPP is a highly potent inhibitor of CYP in mammalian liver, acting on several insecticides and substrates (13) . Several 2-propynyl compounds are activated by CYP oxidation to reactive ketene derivatives (23) . The proposed activated form of PPP is the ketene, which also serves as the intermediate to the propionic acid derivative observed here as a metabolite and identified by synthesis and LC/ MS (Fig. 8) . PPP inhibits nAChR binding in vivo but not in vitro, and without the associated AChE inhibition found with other OPs [i.e., it may be that the combined CYP and nAChR binding inhibition lead to the exceptional potency (10) of this synergist].
The possibility was considered that because PPP-ketene and NMI each have an aryl substituent and electronegative tip, they might bind at the same general nAChR site. To elucidate this theory, we built a homology model of the homomeric Musca α5α5 dimer interface. Musca α5 (uniprot A9XFY4) has high sequence homology with both the Drosophila melanogaster α5 (uniprot Q8T7V5, 99% identity for 200 residues in ligand binding domain) and α7 (uniprot A4GXC7, 98% identity for 200 residues in ligand binding domain) (24) . These sequences are known to form functional homomeric ion channels in Musca (25) and Drosophila (26), so are useful structures for investigations. . *PPP is an exception to these relationships and is not included in the correlation lines. CAR, carbofuran; CAI, carbaryl; CA2, N-propylcarbaryl; OPI, ethoprophos; OP2, profenofos; OP3, tribufos; PAR, paraoxon. The varied compounds were at discriminating topical doses of 3 μg/g for CHL and PAR, 10 μg/g for CAR and OP2, and 100 μg/g for CA1, CA2, OP1, OP3, and PPP.
On docking in the Musca α5α5 and related Myzus α2β1 (27) models, NMI and PPP-ketene adopted the known neonicotinoid orientation found for IMI seen in the 3C79 structure with the electronegative tip of the ligands oriented toward a charge stabilizing region in the active site [in 3C79, these are: Gln-57E, Ser-189A, Cys-190A, Tyr-55E; Myzus: Asn, Val (backbone), Cys, Trp; Musca: Lys, Asn, Cys, Trp]. In Musca, this places the ketene moiety near a lysine nucleophile for possible derivatization ( Fig.  9 and SI Text). This proposal for nAChR binding inhibition by the PPP-ketene is somewhat analogous to inhibition of phosphotriesterase by alkynyl phosphate esters, involving a ketene intermediate acylating a histidine nucleophile (16) .
Concluding Remarks
That the nicotinic receptor plays a critical role in insect control is now even more evident with [ 3 H]NMI as a reporter on in vivo events leading to poisoning (Figs. 1 and 2 ). Neonicotinoids such as NMI and IMI, with exceptional potency and specificity, have a slow nAChR off rate (22) , probably associated with a conformational change, allowing retention at the binding site in the head of a poisoned insect during quick freezing in liquid nitrogen, membrane preparation at 4°C, and assay at 22°C. OP-and MC-induced AChE inhibition and ACh accumulation in the synapse during poisoning apparently give a nAChR conformational change sufficient to inhibit [ 3 H]NMI binding assayed as indicated. The present study emphasized Musca but the radioligand probe and methodology are also applicable to many other insects in studies of resistance mechanisms and species specificity.
Methods
Chemicals. CYC and NMI were synthesized at the East China University of Science and Technology (Shanghai, China). [ 3 H]NMI (9) (60 Ci/mmol) was prepared by Shanghai Ruxu Radiochemicals (Shanghai, China). PPP propionic acid metabolite was made by permanganate oxidation of the butynyl analog of PPP ( Fig. 8 and see SI Text) . All other compounds were from commercial sources. Structures for the neonicotinoids, OPs, and MCs are given in SI Text.
nAChR Binding Assays in Vitro. Musca adults were frozen with liquid nitrogen, shaken to break them into body parts, and the heads isolated by sieving. The frozen heads were homogenized in 0.32 M sucrose, 0.1 mM EDTA, 100 mM sodium phosphate (pH 7.4) using a ground-glass pestle tissue grinder. The homogenate was filtered although four layers of 64-μm-mesh nylon screen and centrifuged at 500 × g for 30 min. The supernatant was collected and again filtered through four layers of 64-μm-mesh nylon screen and centrifuged at 25,000 × g for 60 min at 4°C. The pellet was resuspended in binding buffer consisting of 50 mM sodium chloride and 10 mM sodium phosphate (pH 7.4). These membranes were used fresh or stored at −80°C for up to several weeks without loss of binding activity. Thus, Musca adults anesthetized with carbon dioxide for 10 min were individually treated with the test neonicotinoids dissolved in water or 10% (vol/vol) DMSO by intrathoracic injection (0.4 μL for each Musca) or with test OPs or MCs in acetone (0.4 μL) applied topically to the ventrum of the abdomen. Twenty-five Musca were treated for each dosage with duplicate samples. One hour after treatment and observation of the poisoning signs (see below), the Musca were frozen with liquid nitrogen and after shaking as above the heads were picked out from the other body parts. Twenty heads were homogenized in 1 mL binding buffer at 4°C using a Polytron (Brinkmann Instruments) for 20 s. Each homogenate was centrifuged at 700 × g for 30 min at 4°C. The supernatant was filtered through four layers of 64-μm-mesh nylon screen and then 800 μL was recovered for each binding assay by the in vitro procedure detailed above. Inhibition values were based on two or three independent experiments and adjusted for protein concentration.
AChE Assay. Musca head AChE activity was assayed by the Ellman procedure (29) comparing topically treated insects with untreated controls in each experiment. Five heads (8.5 mg) were homogenized in 2 mL 100 mM sodium phosphate buffer (pH 8.0) using a Polytron, as above, for 15 s. The homogenate was then centrifuged at 700 × g for 30 min at 4°C and the supernatant passed through four layers of 64-μm-mesh nylon screen. Each incubation mixture contained 30-40 μg protein (28) in 200 μL 100 mM potassium phosphate buffer, to which were added 5,5′-dithiobis-2-nitrobenzoic acid and acetylthiocholine (10-and 75-μM final concentration, respectively) and incubated at 25°C to monitor the absorbance change at 405 nm for 30 min.
Poisoning Signs. Poisoning signs for 50 flies were scored 1 h after toxicant injection or topical application using the following rating system for each fly: 0 for normal, 1 for impaired movement (unable to walk or fly), and 2 for dead (failure to move when prodded). The values in the blinded scoring were calculated by the following equation: number of impaired flies plus twice the number of dead flies (i.e., all impaired was rated 50 and complete mortality was scored 100).
CYP Metabolism. Male albino Swiss Webster mice administered PPP (100 mg/kg, i.p.) in DMSO (1 μL/g body weight) were kept in glass metabolism cages. This treatment gave no apparent adverse effects. All mouse experiments were approved by the UC Berkeley Animal Care and Use Committee (ACUC). Urine was collected for 24 h after treatment and stored at −80°C
until LC/MS analysis. Thawed urine (200 μL) was evaporated to dryness under nitrogen at 25°C. Residues were resuspended in 25% (vol/vol) acetonitrile (ACN)/0.1% formic acid aqueous solution (300 μL) and filtered through 0.2-μm nylon for LC/MS analysis. PPP urinary metabolites were analyzed by LC/ MS with electrospray ionization in the positive mode and a Phenomenex Luna 5μ-C18 column (250 × 2.0 mm, 5 μm) using a mobile phase of ACN and 0.1% formic acid beginning with 5% (vol/vol) ACN for 3 min and increasing to 100% (vol/vol) by 25 min at a flow rate of 0.2 mL/min. A final 10-min wash with 5% ACN/ 0.1% formic acid aqueous solution eluted interfering materials. PPP-propionic acid was assigned as a urinary metabolite based on a m/z 272.6 peak at t R 23.9 min absent in control urine and cochromatography of the 272.6 peak with added authentic compound (SI Text).
Calculations. Musca α5α5 homology models were built and refined with the PDB structures 4AQ5 (30) and 3SQ6 as templates. These structures respectively are nAChRs from Torpedo and Lymnaea with 43% and 39% identities and 68% and 61% positives in homology with 205 residues in the ligand binding domain of the Musca α5 structure. We then used an Induced Fit protocol pairing Glide and Prime software (Glide, v5.8, Prime, v3.1; Schrödinger) to dock ACh, NMI and the PPP-ketene in the known neonicotinoid binding pocket of our well-refined α2β1 homology model for Myzus (27) and our new Musca models, including a bridging water as seen in the Aplysia structure 3C79 (31) . (See SI Text for refinement and docking details.)
